New process could be key to understanding complex rearrangements in genome

December 05, 2017

MEDFORD/SOMERVILLE, Mass. (Dec. 5, 2017) -- Understanding complex genomic rearrangements (CGRs), the culprit in the development of many types of cancer and genetic disorders, has always been a challenge because of the limitations of established DNA sequencing techniques. However, a team led by Tufts University biologists has successfully harnessed new technology to develop an approach that could allow for rapid and precise identification of the CGRs involved in disease, cancer and disorder development, which is critical for diagnosis and treatment. The results appeared this week in the December issue of Genome Research.

CGRs are created by DNA double-strand breaks that are not repaired properly. Many types of cancer are characterized by the presence of CGRs. They can also occur at the beginning of life, leading to severe congenital disorders such as Pelizaeus-Merzbacher disease. Repetitive DNA sequences, are also subject to double-strand breaks, which can lead to CGRs. Expansions of repetitive DNA sequences are implicated in hereditary diseases, such as Huntington's disease, fragile X syndrome and Friedreich's ataxia.

Mapping the outcomes of CGRs is crucial for understanding their causes and the potential impact they have on DNA and abnormal cellular formation. Ideally, this mapping would occur through high-resolution imaging. However, high-resolution bio-imaging of CGRs has traditionally been a laborious, time-intensive process that required a good deal of skill.

Led by Ryan J. McGinty, a Ph.D. candidate in the Department of Biology at Tufts University's Graduate School of Arts and Sciences, the research group sought to develop a more efficient process to analyze CGRs.

Use of a new hand-held DNA sequencing device was instrumental to the team's approach. Previous DNA sequencing technologies read DNA in segments of a few hundred nucleotides. The new device, developed by Oxford Nanopore Technologies, allowed researchers to analyze DNA fragments that were tens of thousands of nucleotides in length, showing a fuller picture of the CGRs.

Using a yeast model system, the researchers analyzed the longer fragments to study various CGRs resulting from unstable DNA repeats. Doing so enabled them to read complex events in their entirety and allowed them to uncover the underlying mechanisms that led to each of the complex events.

"This is a groundbreaking approach to analyzing CGRs and determining their origins and outcomes," said Sergei Mirkin, Ph.D., professor and chair of the Department of Biology at Tufts and the study's corresponding author. "This research could significantly advance the way the scientific community deciphers, diagnoses and treats certain genetic disorders and other diseases caused by disruptions of the genome."

The Mirkin Lab at Tufts studies DNA structure and functioning, with a primary focus on various DNA repeats, their role in the maintenance of the genome and their effects on major genetic transactions. A significant part of the lab's research is devoted to unusual DNA structures and their biological roles.
-end-
Tufts biology undergraduate Rachel Rubinstein (A17) and Alexander Neil, an M.D.-Ph.D. candidate at Tufts University's Sackler School of Graduate Biomedical Sciences, also co-authored the paper.

This research was completed in collaboration with the laboratory of Thomas D. Petes, Ph.D., in the Department of Molecular Genetics and Microbiology at Duke University Medical Center.

This work was supported by National Institutes of Health grants to Mirkin and Petes (R01GM60987 and P01GM105473 to Mirkin; R35GM118020 to Petes.)

McGinty, R., Rubinstein, R., Neil, A., Dominska, M., Kiktev, D., Petes, T., Mirkin, S. Nanopore sequencing of complex genomic rearrangements in yeast reveals mechanisms of repeat-mediated double-strand break repair. Genome Research. Advance online publication. doi: 10.1101/gr.228148.117.

The content of this research is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.

About Tufts University

Tufts University, located on campuses in Boston, Medford/Somerville and Grafton, Massachusetts, and in Talloires, France, is recognized among the premier research universities in the United States. Tufts enjoys a global reputation for academic excellence and for the preparation of students as leaders in a wide range of professions. A growing number of innovative teaching and research initiatives span all Tufts campuses, and collaboration among the faculty and students in the undergraduate, graduate and professional programs across the university's schools is widely encouraged.

Tufts University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.